Research Insights
Insights are moderated by the Research Hub team and offer an at-a-glance overview of interesting research findings.
A combined treatment of soy and hop extract is a safe and effective alternative to traditional hormone replacement therapy for improving postmenopausal symptoms.
Randomised Controlled Trial Menopause Soybean
In this double-blinded, randomized controlled trial, researchers administered a combination of soy and hop extract to 78 postmenopausal women with moderate to severe symptoms. Conducted in the gynecological outpatient clinic of a tertiary hospital, all subjects had modified Kupperman Menopausal Index (KMI) scores over 20. Participants either received the treatment or a placebo, as the researchers sought to evaluate their menopausal symptoms over the course of 12 weeks. The changes to their menopausal symptoms were tracked through self-reported KMI scores at multiple intervals. They also gauged measures such as the serum levels of bone metabolism markers, ultrasonographic parameters, hormone profiles, and safety assurances, amongst others.
In terms of test results, after undergoing the 12-week treatment, the group receiving the combined soy and hop extract saw more considerable improvements in their symptoms compared to the placebo group. They particularly noted notable enhancements in conditions like fatigue, paresthesia, arthralgia, and myalgia, palpitations, and vaginal dryness. Lowered increases in urine N-telopeptide, a biomarker for bone metabolism, were observed in treatment group participants aged 50 and older. Meanwhile, endometrial thickness and hormonal profiles did not display any significant shifts in either group. Importantly, throughout the trial, no harmful side effects or events arose, speaking to the safety of the treatment.
View Article
Hop extract, particularly its component 8-Prenylnaringenin (8-PN), demonstrates potential in alleviating symptoms common in menopause such as osteoporosis, vasomotoric disturbances, and sexual motivation.
Hot Flushes Menopause Osteoporosis
The methodology of this research involved identifying the major constituents of hop extract, with a focus on 8-Prenylnaringenin (8-PN) due to its estrogenic qualities. Several in vivo studies were conducted to explore the potential of hop extract and 8-PN in mitigating climacteric symptoms. Clinical studies conducted have mainly centered around menopausal discomforts, still, these studies provided broad results.
In the discussion of the results, it was found that hop extract, and more prominently, 8-PN, show promise in alleviating menopausal symptoms such as osteoporosis, vasomotoric issues, and sexual desire. Although 8-PN primarily activates the estrogen receptor α and presents only slight uterotrophic attributes, it also brings about estrogenic effects on the mammary gland. The results indicate potential application of 8-PN and hop extract in alleviating symptoms commonly associated with menopause.
View Article
Review Articles
Review articles summarise and critically evaluate the current state of research on a specific topic or field by synthesising multiple primary research studies.
Study Protocols
Published study protocols are detailed plans that outline the objectives, methodology, statistical analyses, and organisation of a research study that have been made publicly available for others to review and use as a reference.
Presentation Slides
Chinese Medicine Research Hub
Randomised Controlled Trial
A combined treatment of soy and hop extract is a safe and effective alternative to traditional hormone replacement therapy for improving postmenopausal symptoms.
2021 The Journal of Alternative and Complementary Medicine Efficacy and Safety of a Standardized Soy and Hop Extract on Menopausal Symptoms: A 12-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Kim HI, Kim MK, Lee I, Yun J, Kim EH, Seo SK
Chinese Medicine Research Hub
Hop extract, particularly its component 8-Prenylnaringenin (8-PN), demonstrates potential in alleviating symptoms common in menopause such as osteoporosis, vasomotoric disturbances, and sexual motivation.
2013 Neuropediatrics Hop Extracts and Hop Substances in Treatment of Menopausal Complaints
Keiler A, Zierau O, Kretzschmar G
Executive Summary
Write an executive summary in the form of a blog article on the topic of "Research into Chinese medicine treatment for Hops" summarising the research below and using language that can be easily understood by patients and avoiding medical jargon using a professional and caring tone of voice.
Write an executive summary in the form of a blog article on the topic of "Researched Chinese medicine treatments for Hops" summarising the research below in an objective and easy to understand way, and using language that can be easily understood by patients. Group the article into Chinese medicine treatments first, followed by nutrition and other treatments. Avoid using medical jargon and use a professional and caring tone of voice.
Write me a concise but easy to understand executive summary on the topic of "Chinese medicine treatments for Hops" based on the following research that I will give you. Your summary should be 2 paragraphs long in Australian English spelling and include references to the studies.
A Randomised Controlled Trial published in 2021 in the journal The Journal of Alternative and Complementary Medicine found that A combined treatment of soy and hop extract is a safe and effective alternative to traditional hormone replacement therapy for improving postmenopausal symptoms. In this double-blinded, randomized controlled trial, researchers administered a combination of soy and hop extract to 78 postmenopausal women with moderate to severe symptoms. Conducted in the gynecological outpatient clinic of a tertiary hospital, all subjects had modified Kupperman Menopausal Index (KMI) scores over 20. Participants either received the treatment or a placebo, as the researchers sought to evaluate their menopausal symptoms over the course of 12 weeks. The changes to their menopausal symptoms were tracked through self-reported KMI scores at multiple intervals. They also gauged measures such as the serum levels of bone metabolism markers, ultrasonographic parameters, hormone profiles, and safety assurances, amongst others.
In terms of test results, after undergoing the 12-week treatment, the group receiving the combined soy and hop extract saw more considerable improvements in their symptoms compared to the placebo group. They particularly noted notable enhancements in conditions like fatigue, paresthesia, arthralgia, and myalgia, palpitations, and vaginal dryness. Lowered increases in urine N-telopeptide, a biomarker for bone metabolism, were observed in treatment group participants aged 50 and older. Meanwhile, endometrial thickness and hormonal profiles did not display any significant shifts in either group. Importantly, throughout the trial, no harmful side effects or events arose, speaking to the safety of the treatment.
A published in 2013 in the journal Neuropediatrics found that Hop extract, particularly its component 8-Prenylnaringenin (8-PN), demonstrates potential in alleviating symptoms common in menopause such as osteoporosis, vasomotoric disturbances, and sexual motivation. The methodology of this research involved identifying the major constituents of hop extract, with a focus on 8-Prenylnaringenin (8-PN) due to its estrogenic qualities. Several in vivo studies were conducted to explore the potential of hop extract and 8-PN in mitigating climacteric symptoms. Clinical studies conducted have mainly centered around menopausal discomforts, still, these studies provided broad results.
In the discussion of the results, it was found that hop extract, and more prominently, 8-PN, show promise in alleviating menopausal symptoms such as osteoporosis, vasomotoric issues, and sexual desire. Although 8-PN primarily activates the estrogen receptor α and presents only slight uterotrophic attributes, it also brings about estrogenic effects on the mammary gland. The results indicate potential application of 8-PN and hop extract in alleviating symptoms commonly associated with menopause.